Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402-Reference-Cited by-同舟云学术

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

Published:2012-01-27 Issue:6 Volume:51 Page:768-773
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Nogami Naoyuki,Hotta Katsuyuki,Segawa Yoshihiko,Takigawa Nagio,Hosokawa Shinobu,Oze Isao,Fujii Masanori,Ichihara Eiki,Shibayama Takuo,Tada Atsuhiko,Hamada Noboru,Uno Masatoshi,Tamaoki Akihiko,Kuyama Shoichi,Ikeda Genyo,Osawa Masahiro,Takata Saburo,Tabata Masahiro,Tanimoto Mitsune,Kiura Katsuyuki

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2011.648342

Reference31 articles.

1. Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

2. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

3. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

4. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320);Investigational New Drugs;2020-11-07

2. Development of a Split Esterase for Protein–Protein Interaction-Dependent Small-Molecule Activation;ACS Central Science;2019-09-24

3. A review on engineering polymer drug conjugates to improve combination chemotherapy;Current Opinion in Colloid & Interface Science;2017-09

4. Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma;Molecular Therapy - Oncolytics;2017-03

5. Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer;International Journal of Clinical Oncology;2015-08-13